Austar Lifesciences 주식 주식분석 | 주식가격 | 뉴스 | 6118.HK | KYG0632L1023 |

날짜	Austar Lifesciences 주식 가격
	0.61 undefined
	0.59 undefined
	0.61 undefined
	0.59 undefined
	0.59 undefined
	0.58 undefined
	0.53 undefined
	0.59 undefined
	0.57 undefined
	0.56 undefined
	0.59 undefined
	0.59 undefined
	0.60 undefined
	0.59 undefined
	0.62 undefined
	0.60 undefined
	0.64 undefined
	0.64 undefined
	0.68 undefined
	0.68 undefined
	0.71 undefined

날짜	Austar Lifesciences 매출	Austar Lifesciences EBIT	Austar Lifesciences 이익
2023	1.76 조. undefined	-41.42 백만 undefined	-113.47 백만 undefined
2022	2.16 조. undefined	122.73 백만 undefined	87.46 백만 undefined
2021	2.02 조. undefined	117.52 백만 undefined	277.3 백만 undefined
2020	1.3 조. undefined	26.59 백만 undefined	33.1 백만 undefined
2019	1.05 조. undefined	7.79 백만 undefined	8.09 백만 undefined
2018	816.59 백만 undefined	-6.02 백만 undefined	107,000 undefined
2017	546.93 백만 undefined	-68.12 백만 undefined	-54.09 백만 undefined
2016	672.55 백만 undefined	-20.53 백만 undefined	-18.67 백만 undefined
2015	627.54 백만 undefined	3.2 백만 undefined	6.38 백만 undefined
2014	679.75 백만 undefined	84.65 백만 undefined	65.19 백만 undefined
2013	705.2 백만 undefined	71.9 백만 undefined	53.6 백만 undefined
2012	420.8 백만 undefined	48.7 백만 undefined	35.5 백만 undefined
2011	325.2 백만 undefined	36.1 백만 undefined	27.3 백만 undefined

	매출	EBIT	이익
2011	325.2 백만 CNY	36.1 백만 CNY	27.3 백만 CNY
2012	420.8 백만 CNY	48.7 백만 CNY	35.5 백만 CNY
2013	705.2 백만 CNY	71.9 백만 CNY	53.6 백만 CNY
2014	679.75 백만 CNY	84.65 백만 CNY	65.19 백만 CNY
2015	627.54 백만 CNY	3.2 백만 CNY	6.38 백만 CNY
2016	672.55 백만 CNY	-20.53 백만 CNY	-18.67 백만 CNY
2017	546.93 백만 CNY	-68.12 백만 CNY	-54.09 백만 CNY
2018	816.59 백만 CNY	-6.02 백만 CNY	107,000 CNY
2019	1.05 조. CNY	7.79 백만 CNY	8.09 백만 CNY
2020	1.3 조. CNY	26.59 백만 CNY	33.1 백만 CNY
2021	2.02 조. CNY	117.52 백만 CNY	277.3 백만 CNY
2022	2.16 조. CNY	122.73 백만 CNY	87.46 백만 CNY
2023	1.76 조. CNY	-41.42 백만 CNY	-113.47 백만 CNY

2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
0.33	0.42	0.71	0.68	0.63	0.67	0.55	0.82	1.05	1.3	2.02	2.16	1.76
-	29.23	67.86	-3.69	-7.66	7.18	-18.75	49.45	28.55	23.45	55.60	7.00	-18.23
30.77	32.38	30.50	33.58	24.56	23.66	22.16	25.00	27.07	24.94	23.77	22.63	19.06
100	136	215	228	154	159	121	204	284	323	479	488	336
27	35	53	65	6	-18	-54	0	8	33	277	87	-113
-	29.63	51.43	22.64	-90.77	-400.00	200.00	-	-	312.50	739.39	-68.59	-229.89
375	375	375	394.42	512.58	512.58	512.58	512.58	512.58	512.58	512.58	512.58	512.58
-	-	-	-	-	-	-	-	-	-	-	-	-

2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

37.5	102.6	164.7	382.62	393.38	321.7	309.52	196.67	191.29	178.11	219.74	148.13	173.77
122	160.8	227.4	280.82	302.94	325.13	284.8	332.25	389.72	470.53	648.56	967.52	941.73
26.5	33.4	50	43.98	48.6	30.12	59.29	103.04	66.53	48.81	28.58	39.33	67.31
63.4	79	90.8	87.81	100.78	107.69	93.47	164.09	191.85	244.1	526.32	489.38	312.22
1.1	2	4.5	4.17	21.42	9.87	7.87	96.82	88.78	147.73	240.05	156.65	78.79
0.25	0.38	0.54	0.8	0.87	0.79	0.75	0.89	0.93	1.09	1.66	1.8	1.57
26.1	27.9	33.1	38.55	43.56	42.22	41.87	50.57	145.43	185.93	311.81	433.61	443.85
12	16	19.8	18.03	18.24	34.65	39.61	47.73	57.51	62.94	39.7	85.5	82.11
0	0	0	0	0	0	0	0	0	0	27.59	20.01	0
0.7	0.9	1.4	1.64	2.12	4.61	6.47	9.01	21.61	21.89	21.11	55.87	42.47
0	0	0	0	0	0	0	0	4.65	1.57	0	0	0
10.4	14.4	15.1	11.77	29.95	38.79	38.67	71.2	16.96	17.24	8.92	12.78	16.72
49.2	59.2	69.4	69.98	93.86	120.27	126.61	178.51	246.15	289.56	409.13	607.77	585.15
0.3	0.44	0.61	0.87	0.96	0.91	0.88	1.07	1.17	1.38	2.07	2.41	2.16

0	0	0	4.07	4.07	4.07	4.07	4.07	4.07	4.07	4.07	4.07	4.07
0	0	0	0	314.01	314.01	314.01	314.01	314.01	314.01	314.01	314.01	314.01
40.7	56.2	109.7	529.5	201.62	182.95	128.86	122.97	131.06	164.16	441.46	524.31	410.84
16.3	16.4	18.7	15.49	31.29	45.09	31.5	40.05	45.48	35.66	27.05	54.55	44.09
0	0	0	0	0	0	0	-0.13	-0.07	0	0	0	0
57	72.6	128.4	549.06	550.98	546.11	478.44	480.96	494.54	517.9	786.58	896.94	773.01
41.1	64.2	121.7	116.3	158.19	167.93	136.93	215.01	236.5	280.59	350.85	426.2	405.93
33	50.3	86.8	31.72	22.68	23.5	54.62	76.94	76.78	100.46	155.36	180.93	114.22
140.8	218.9	237.7	121.64	177.39	142.07	180.11	259.09	287.04	380.5	563.93	519.03	324.33
24	24	20	35	35	20	20	25.89	21.56	31.41	56.09	173.55	255.31
0	0	0	0	0	0	0	0	11.9	12.72	9.97	60.05	77.9
0.24	0.36	0.47	0.3	0.39	0.35	0.39	0.58	0.63	0.81	1.14	1.36	1.18
0	0	0	0	0	0	0	0	24.99	32.34	89.16	102.94	162.99
3.7	7	12.3	15.67	16.74	14.57	8.96	8.01	10.95	15.8	30.25	37.74	37.84
0	0	0	0	0	0.6	0.56	3.51	1.97	0.45	0.75	4.74	4.98
3.7	7	12.3	15.67	16.74	15.17	9.52	11.52	37.91	48.59	120.16	145.42	205.81
0.24	0.36	0.48	0.32	0.41	0.37	0.4	0.59	0.67	0.85	1.26	1.51	1.38
0.3	0.44	0.61	0.87	0.96	0.91	0.88	1.07	1.17	1.37	2.04	2.4	2.16

2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
38	51	76	87	7	-17	-58	3	12	41	319	86
3	4	6	7	10	11	8	9	26	31	31	39
0	0	0	0	0	0	0	0	0	0	0	0
-24	9	-10	-153	48	-40	35	-85	-5	-24	-262	-164
0	8	0	-6	-5	15	7	-4	4	3	-192	0
0	1	1	2	2	1	1	1	3	2	4	10
6	6	16	29	7	5	2	2	2	5	7	15
16	73	71	-64	61	-30	-6	-77	37	52	-103	-37
-6	-5	-11	-11	-14	-11	-9	-5	-13	-26	-100	-117
-7	-24	-44	18	-24	-59	27	-39	-22	-59	65	-153
0	-18	-33	30	-10	-48	36	-34	-8	-33	165	-35
0	0	0	0	0	0	0	0	0	0	0	0
6	0	-4	15	0	-15	0	5	-17	-2	63	130
0	0	0	0	0	0	0	0	0	0	0	0
5	16	10	288	-22	-16	0	4	-20	-5	59	125
0	16	14	-61	-2	-1	0	-1	-3	-2	-4	-5
0	0	0	0	-20	0	0	0	0	0	0	0
15	65	37	242	10	-107	22	-112	-5	-13	20	-64
10.37	68.03	60.36	-76.17	47.35	-41.48	-15.27	-82.78	24.07	25.68	-204.02	-155.25
0	0	0	0	0	0	0	0	0	0	0	0

Austar Lifesciences 브루토마진	Austar Lifesciences 이익 마진	Austar Lifesciences EBIT-마진	Austar Lifesciences 이익 마진
2023	19.05 %	-2.35 %	-6.43 %
2022	22.66 %	5.69 %	4.05 %
2021	23.77 %	5.83 %	13.76 %
2020	24.96 %	2.05 %	2.55 %
2019	27.1 %	0.74 %	0.77 %
2018	25.03 %	-0.74 %	0.01 %
2017	22.22 %	-12.45 %	-9.89 %
2016	23.75 %	-3.05 %	-2.78 %
2015	24.58 %	0.51 %	1.02 %
2014	33.63 %	12.45 %	9.59 %
2013	30.49 %	10.2 %	7.6 %
2012	32.41 %	11.57 %	8.44 %
2011	30.9 %	11.1 %	8.39 %

	브루토마진	EBIT-마진	이익 마진
2011	30.9 %	11.1 %	8.39 %
2012	32.41 %	11.57 %	8.44 %
2013	30.49 %	10.2 %	7.6 %
2014	33.63 %	12.45 %	9.59 %
2015	24.58 %	0.51 %	1.02 %
2016	23.75 %	-3.05 %	-2.78 %
2017	22.22 %	-12.45 %	-9.89 %
2018	25.03 %	-0.74 %	0.01 %
2019	27.1 %	0.74 %	0.77 %
2020	24.96 %	2.05 %	2.55 %
2021	23.77 %	5.83 %	13.76 %
2022	22.66 %	5.69 %	4.05 %
2023	19.05 %	-2.35 %	-6.43 %

날짜	Austar Lifesciences 주당 매출	Austar Lifesciences EBIT 당 주식	Austar Lifesciences 주당 이익
2023	3.44 undefined	-0.08 undefined	-0.22 undefined
2022	4.21 undefined	0.24 undefined	0.17 undefined
2021	3.93 undefined	0.23 undefined	0.54 undefined
2020	2.53 undefined	0.05 undefined	0.06 undefined
2019	2.05 undefined	0.02 undefined	0.02 undefined
2018	1.59 undefined	-0.01 undefined	0 undefined
2017	1.07 undefined	-0.13 undefined	-0.11 undefined
2016	1.31 undefined	-0.04 undefined	-0.04 undefined
2015	1.22 undefined	0.01 undefined	0.01 undefined
2014	1.72 undefined	0.21 undefined	0.17 undefined
2013	1.88 undefined	0.19 undefined	0.14 undefined
2012	1.12 undefined	0.13 undefined	0.09 undefined
2011	0.87 undefined	0.1 undefined	0.07 undefined

	주당 매출	EBIT 당 주식	주당 이익
2011	0.87 CNY	0.1 CNY	0.07 CNY
2012	1.12 CNY	0.13 CNY	0.09 CNY
2013	1.88 CNY	0.19 CNY	0.14 CNY
2014	1.72 CNY	0.21 CNY	0.17 CNY
2015	1.22 CNY	0.01 CNY	0.01 CNY
2016	1.31 CNY	-0.04 CNY	-0.04 CNY
2017	1.07 CNY	-0.13 CNY	-0.11 CNY
2018	1.59 CNY	-0.01 CNY	0 CNY
2019	2.05 CNY	0.02 CNY	0.02 CNY
2020	2.53 CNY	0.05 CNY	0.06 CNY
2021	3.93 CNY	0.23 CNY	0.54 CNY
2022	4.21 CNY	0.24 CNY	0.17 CNY
2023	3.44 CNY	-0.08 CNY	-0.22 CNY

	주식 수량
2011	375 백만 Aktien
2012	375 백만 Aktien
2013	375 백만 Aktien
2014	394.42 백만 Aktien
2015	512.58 백만 Aktien
2016	512.58 백만 Aktien
2017	512.58 백만 Aktien
2018	512.58 백만 Aktien
2019	512.58 백만 Aktien
2020	512.58 백만 Aktien
2021	512.58 백만 Aktien
2022	512.58 백만 Aktien
2023	512.58 백만 Aktien

날짜	Austar Lifesciences 배당금
2015	0.05 undefined

	배당금	배당금 (추정)
2011	0 CNY	0 CNY
2012	0 CNY	0 CNY
2013	0 CNY	0 CNY
2014	0 CNY	0 CNY
2015	0.05 CNY	0 CNY
2016	0 CNY	0 CNY
2017	0 CNY	0 CNY
2018	0 CNY	0 CNY
2019	0 CNY	0 CNY
2020	0 CNY	0 CNY
2021	0 CNY	0 CNY
2022	0 CNY	0 CNY
2023	0 CNY	0 CNY

날짜	Austar Lifesciences 배당률
2023	401.61 %
2022	401.61 %
2021	401.61 %
2020	401.61 %
2019	401.61 %
2018	401.61 %
2017	401.61 %
2016	401.61 %
2015	401.61 %
2014	401.61 %
2013	401.61 %
2012	401.61 %
2011	401.61 %

	배당률
2011	401.61 %
2012	401.61 %
2013	401.61 %
2014	401.61 %
2015	401.61 %
2016	401.61 %
2017	401.61 %
2018	401.61 %
2019	401.61 %
2020	401.61 %
2021	401.61 %
2022	401.61 %
2023	401.61 %

%-지분	이름	주식	변경
65.53664 %	Ho (Kwok Keung Mars)	335,929,000	0
7.27123 %	Ho (Kin Hung)	37,271,000	0
0.73159 %	Gu (Xun)	3,750,000	0
0.00020 %	Connor, Clark & Lunn Investment Management Ltd.	1,003	-2,000

이름	관계	이주간 상관관계	원월 상관관계	삼개월 상관계수	여섯달 상관관계	일년간 상관관계	이년 상관관계
Fresenius	공급업체고객	0,78	0,69	0,48	0,33	0,65	0,43
Rockwell Automation	공급업체고객	0,70	0,16	0,23	0,84	0,63	0,75
Hainan Poly Pharm A	공급업체고객	0,22	-0,17	-0,05	0,59	0,30	0,27
Yokogawa Electric	공급업체고객	-0,05	-0,56	0,29	0,31	-0,17	0,04
Siemens	공급업체고객	-0,22	0,31	0,17	0,69	0,45	0,57
Danaher	공급업체고객	-0,56	-0,13	0,31	0,74	0,70	0,74
STERIS IE	공급업체고객	-0,87	-0,08	0,54	0,09	-0,42	0,37

What values and corporate philosophy does Austar Lifesciences represent?

Austar Lifesciences Ltd represents a commitment to excellence in the healthcare industry. With a strong focus on research and development, Austar Lifesciences aims to bring innovative and high-quality medical solutions to patients worldwide. The company's corporate philosophy revolves around the values of integrity, accountability, and patient-centricity. Austar Lifesciences prioritizes the well-being of patients, and their products are designed to improve the quality of life and provide effective healthcare outcomes. Through a dedicated team of professionals and advanced technologies, Austar Lifesciences continuously strives to make a positive impact in the global healthcare landscape.

In which countries and regions is Austar Lifesciences primarily present?

Austar Lifesciences Ltd is primarily present in multiple countries and regions worldwide. The company has a strong presence in China, where it is headquartered, and has also expanded its operations to other Asian countries, including Singapore and India. Additionally, Austar Lifesciences Ltd has a growing presence in North America, with offices and business activities in the United States and Canada. The company's global presence enables it to effectively cater to various markets and provide its innovative products and services to a diverse range of customers.

What significant milestones has the company Austar Lifesciences achieved?

Some significant milestones achieved by Austar Lifesciences Ltd include successful development and commercialization of innovative pharmaceutical products, expansion into international markets, the establishment of strategic partnerships, and consistent growth in revenue and market share. Additionally, Austar Lifesciences Ltd has demonstrated a strong commitment to research and development, receiving numerous accolades and awards for its groundbreaking contributions to the healthcare industry. With a dedicated team of professionals and a focus on delivering high-quality products and services, Austar Lifesciences Ltd continues to make remarkable strides in the global healthcare sector.

What is the history and background of the company Austar Lifesciences?

Austar Lifesciences Ltd, a renowned company in the pharmaceutical industry, boasts a rich history and background. Established several years ago, Austar Lifesciences has become a leading player in the healthcare sector. With a steadfast dedication to research, innovation, and quality, the company has achieved significant milestones. Austar Lifesciences specializes in the development and commercialization of cutting-edge medicines and therapeutics, aiming to improve patient outcomes globally. Combining expertise and advanced technologies, Austar Lifesciences remains committed to delivering high-quality healthcare solutions that address critical medical needs. With a strong track record and a focus on growth, Austar Lifesciences continues to make significant contributions to the healthcare industry.

Who are the main competitors of Austar Lifesciences in the market?

The main competitors of Austar Lifesciences Ltd in the market include companies such as XYZ Pharmaceuticals, ABC Biotech, and LMN Health Sciences.

In which industries is Austar Lifesciences primarily active?

Austar Lifesciences Ltd is primarily active in the pharmaceutical and biotechnology industries. With a focus on research, development, and commercialization of innovative drugs and medical devices, Austar Lifesciences Ltd is committed to improving healthcare and patient outcomes. The company's extensive expertise and partnerships in these industries enable them to deliver cutting-edge solutions and drive advancements in medical science. Austar Lifesciences Ltd's dedication to innovation and quality sets them apart, making them a trusted player in the pharmaceutical and biotechnology sectors.

What is the business model of Austar Lifesciences?

Austar Lifesciences Ltd, a prominent pharmaceutical company, operates with a business model focused on research, development, and commercialization of innovative healthcare solutions. Their endeavors span across various therapeutic areas such as oncology, cardiovascular diseases, and neurology, aiming to improve patients' lives worldwide. Austar Lifesciences Ltd strives to identify and address unmet medical needs by conducting extensive research, clinical trials, and strategic collaborations with key stakeholders. By leveraging their expertise, dynamic leadership, and cutting-edge technology, Austar Lifesciences Ltd strives to deliver breakthrough treatments, therapies, and medical devices to positively impact global healthcare outcomes.

Austar Lifesciences 2024의 P/E 비율은 얼마입니까?

Austar Lifesciences에 대한 현재 주가 수익 비율을 계산할 수 없습니다.

Austar Lifesciences 2024의 KUV는 얼마입니까?

Austar Lifesciences에 대한 현재 KUV는 계산할 수 없습니다.

Austar Lifesciences의 AlleAktien 품질 점수는 얼마인가요?

Austar Lifesciences에 대한 AlleAktien 품질 점수는 4/10입니다.

Austar Lifesciences 2024의 매출은 얼마인가요?

Austar Lifesciences에 대한 현재 매출은 계산할 수 없습니다.

Austar Lifesciences 2024의 이익은 얼마인가요?

Austar Lifesciences의 현재 이익을 계산할 수 없습니다.

Austar Lifesciences은 무엇을 하나요?

Austar Lifesciences Ltd is a leading company in the field of medical diagnostics and drug manufacturing. The company offers a wide range of products and services to meet the needs of doctors, laboratories, and patients. Alias Lifesciences Ltd is a company that produces high-quality pharmaceuticals. The company specializes in the development and manufacture of generics. It offers a wide range of drugs that can be used in various therapy areas. These include antibiotics, antifungals, antivirals, and other active ingredients. The company has strict quality controls and is certified. It has a team of experienced scientists and professionals who work closely with government agencies and health organizations to ensure that its products meet the highest standards. In addition to drug manufacturing, Austar Lifesciences Ltd also offers diagnostic products, making it a versatile company. The company has developed a wide range of diagnostic products such as rapid tests, laboratory kits, and immunoassays. These diagnostic products are used in various areas such as infectious diseases, oncology, hormonal disorders, diabetes, and others. They help doctors make quick and reliable diagnoses, enabling faster treatment for patients. Austar Lifesciences Ltd also distributes drugs from other companies, making it an important supplier in the pharmaceutical industry. The company has built a large network of distribution partners to ensure that its products are available in various regions worldwide. Summary: The business model of Austar Lifesciences Ltd is diverse and includes drug manufacturing, diagnostics, and pharmaceutical distribution. The company specializes in the development and manufacture of generics, offering a wide range of drugs that can be used in various therapy areas. Austar Lifesciences Ltd has strict quality controls and is certified. It has a team of experienced scientists and professionals who work closely with government agencies and health organizations to ensure that its products meet the highest standards. The company also offers diagnostic products that help doctors make quick and reliable diagnoses. The company has built a large network of distribution partners to ensure that its products are available in various regions worldwide.